Healthcare of Ontario Pension Plan Trust Fund Increases Stock Position in Amedisys, Inc. (NASDAQ:AMED)

Healthcare of Ontario Pension Plan Trust Fund lifted its holdings in shares of Amedisys, Inc. (NASDAQ:AMED) by 226.1% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 88,712 shares of the health services provider’s stock after buying an additional 61,512 shares during the quarter. Healthcare of Ontario Pension Plan Trust Fund owned about 0.27% of Amedisys worth $8,562,000 at the end of the most recent quarter.

A number of other institutional investors also recently modified their holdings of AMED. KBC Group NV purchased a new stake in Amedisys in the 3rd quarter worth approximately $63,000. Innealta Capital LLC purchased a new stake in Amedisys in the 2nd quarter worth approximately $64,000. Signaturefd LLC raised its position in shares of Amedisys by 88.2% during the 2nd quarter. Signaturefd LLC now owns 1,131 shares of the health services provider’s stock valued at $104,000 after buying an additional 530 shares in the last quarter. CWM LLC raised its position in shares of Amedisys by 14.5% during the 3rd quarter. CWM LLC now owns 2,190 shares of the health services provider’s stock valued at $211,000 after buying an additional 277 shares in the last quarter. Finally, Crossmark Global Holdings Inc. purchased a new stake in shares of Amedisys during the 3rd quarter valued at $243,000. 94.36% of the stock is currently owned by hedge funds and other institutional investors.

Amedisys Stock Performance

Amedisys stock opened at $91.41 on Friday. The firm’s fifty day moving average price is $94.86 and its 200-day moving average price is $95.64. The company has a debt-to-equity ratio of 0.05, a quick ratio of 1.19 and a current ratio of 1.19. The stock has a market cap of $2.99 billion, a P/E ratio of 36.27, a price-to-earnings-growth ratio of 1.92 and a beta of 0.78. Amedisys, Inc. has a fifty-two week low of $88.81 and a fifty-two week high of $98.95.

Amedisys (NASDAQ:AMED) last posted its quarterly earnings results on Wednesday, November 6th. The health services provider reported $1.00 earnings per share for the quarter, missing the consensus estimate of $1.19 by ($0.19). Amedisys had a return on equity of 12.20% and a net margin of 3.57%. The business had revenue of $587.67 million during the quarter, compared to the consensus estimate of $586.75 million. During the same period in the prior year, the firm earned $0.98 earnings per share. The business’s revenue for the quarter was up 5.7% on a year-over-year basis. On average, equities research analysts expect that Amedisys, Inc. will post 4.55 earnings per share for the current fiscal year.

About Amedisys

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.